Y Intercept Hong Kong Ltd lessened its holdings in shares of Dolby Laboratories (NYSE:DLB – Free Report) by 35.9% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 18,610 shares of the electronics maker’s stock after selling 10,429 shares during the quarter. Y Intercept Hong Kong Ltd’s holdings in Dolby Laboratories were worth $1,118,000 at the end of the most recent quarter.
Other large investors have also modified their holdings of the company. Boothbay Fund Management LLC lifted its stake in shares of Dolby Laboratories by 4.1% in the second quarter. Boothbay Fund Management LLC now owns 4,020 shares of the electronics maker’s stock worth $299,000 after buying an additional 157 shares in the last quarter. Covestor Ltd grew its stake in Dolby Laboratories by 6.0% during the 4th quarter. Covestor Ltd now owns 3,088 shares of the electronics maker’s stock valued at $198,000 after acquiring an additional 175 shares in the last quarter. Fifth Third Bancorp raised its holdings in Dolby Laboratories by 34.7% in the 4th quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock valued at $48,000 after acquiring an additional 192 shares during the last quarter. Raymond James Financial Inc. raised its holdings in Dolby Laboratories by 1.0% in the 2nd quarter. Raymond James Financial Inc. now owns 24,344 shares of the electronics maker’s stock valued at $1,808,000 after acquiring an additional 235 shares during the last quarter. Finally, Asset Management One Co. Ltd. lifted its stake in Dolby Laboratories by 2.4% in the 4th quarter. Asset Management One Co. Ltd. now owns 11,240 shares of the electronics maker’s stock worth $732,000 after purchasing an additional 268 shares in the last quarter. Hedge funds and other institutional investors own 58.56% of the company’s stock.
Dolby Laboratories Stock Performance
Shares of Dolby Laboratories stock traded down $0.40 during trading hours on Friday, hitting $49.72. The company’s stock had a trading volume of 501,978 shares, compared to its average volume of 958,286. The firm has a fifty day moving average of $53.94 and a 200-day moving average of $60.07. Dolby Laboratories has a twelve month low of $48.66 and a twelve month high of $77.00. The stock has a market cap of $4.70 billion, a price-to-earnings ratio of 19.65 and a beta of 0.81.
Dolby Laboratories Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th were given a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a dividend yield of 2.9%. The ex-dividend date was Tuesday, May 12th. Dolby Laboratories’s payout ratio is currently 56.92%.
Insider Activity at Dolby Laboratories
In related news, CFO Robert J. Park sold 4,895 shares of the business’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $56.68, for a total value of $277,448.60. Following the completion of the sale, the chief financial officer directly owned 81,490 shares of the company’s stock, valued at $4,618,853.20. The trade was a 5.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CMO Todd Pendleton sold 11,876 shares of the company’s stock in a transaction dated Friday, May 22nd. The shares were sold at an average price of $54.55, for a total value of $647,835.80. Following the completion of the sale, the chief marketing officer directly owned 41,480 shares of the company’s stock, valued at approximately $2,262,734. This trade represents a 22.26% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 47,458 shares of company stock worth $2,639,537. Corporate insiders own 37.93% of the company’s stock.
Wall Street Analysts Forecast Growth
Several research analysts have recently weighed in on the company. Rosenblatt Securities restated a “buy” rating and set a $85.00 target price on shares of Dolby Laboratories in a report on Thursday, June 11th. Barrington Research reiterated an “outperform” rating and set a $90.00 price objective on shares of Dolby Laboratories in a research report on Monday, June 15th. Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Wednesday, June 24th. Finally, Wall Street Zen upgraded Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Saturday, May 30th. Three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $90.75.
Check Out Our Latest Analysis on DLB
Dolby Laboratories Company Profile
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Featured Stories
- Five stocks we like better than Dolby Laboratories
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
